• 21
    Mustafa Lawar, Ismail Yalcin, Kayhan Bolelli, Hakan Sezgin Sayiner, Fatma Kandemirli, “QSAR Study on Thiosemicarbazone Derivatives as Ribonucleotide Reductase Inhibitors”, Electronic Letters on Science&Engineering, 13(2) Special Issue: p37-38, (2017). [tüm metin]
  • 20
    E. Foto, F. Zilifdar, S. Yilmaz, T. Saracbasi, I. Yalcin, N. Diril, "Mutagenicity of a series efficacious benzoxazine derivatives – a new approach to evaluate ames test data", The FEBS Journal, 283 (Suppl. 1): 186-187, (2016). DOI: 10.1111/febs.13808. [tüm metin]
  • 19
    Oksuzoğlu E., Foto E., Zilifdar F., Ertan-Bolelli T., Bolelli K., “A study on antiproliferative and genotoxic potentials in L929 and HeLa cell lines -the mutagenic activities in Salmonella strains of novel 2,5-disubstitutedbenzoxazole derivatives”, The FEBS Journal, 283 (Suppl. 1): 85, (2016). DOI: 10.1111/febs.13807. [tüm metin]
  • 18
    T. Ozkan, Y. Hekmatshoar, T. Ertan Bolelli, M. Beksac, E. Aki Yalcin, I. Yalcin, A. Sunguroglu, "A benzamide derivative XT5 and imatinib combination induced apoptosis in Imatinib resistant K562 cell line", The FEBS Journal, 283 (Suppl. 1): 162, (2016). DOI: 10.1111/febs.13808. [tüm metin]
  • 17
    F. Zilifdar, E. Foto, T. Ertan-Bolelli, I. Yalcin, E. Aki, N. Diril, "Differences of global methylation profiles in L929 and HeLa cells treated with a serial benzoxazole and benzamide derivatives", The FEBS Journal, 283 (Suppl. 1): 259, (2016). DOI: 10.1111/febs.13808. [tüm metin]
  • 16
    Meral Beksac, Pinar Ataca, Berna Kirazli, Klara Dalva, Andry Nur Hidayat, Ismail Yalcin, Esin Aki-Yalcin, Tulin Ozkan, Xenofon Papanikalaou, Saad Z. Usmani, Erming Tian, "Expression and in vitro binding of Protease Activated Receptor1 (PAR1) with novel anti-PAR1 molecules: data on Fresh Myeloma Marrow Plasma Cells And Human Myeloma Cell Lines", Blood Journal, 126(23), 4440-4440 (3 Dec 2015).
  • 15
    Fatma Zilifdar, Egemen Foto, Omur Bostanci, Sibel Sari, Kayhan Bolelli, Ismail Yalcin, Nuran Diril, “Mutagenic Activity of 4 Newly Synthesized Heterocyclic Compounds”, The Turkish Journal of Occupational / Environmental Medicine and Safety (TURJOEM), 1(1), Suppl. 1: 14, (2015). [tüm metin]
  • 14
    Egemen Foto, Fatma Zilifdar, Sibel Sari, Omur Bostanci, Kayhan Bolelli, Ismail Yalcin, Nuran Diril, “Mutagenic Activity of Some Benzothiazole Derivatives”, The Turkish Journal of Occupational / Environmental Medicine and Safety (TURJOEM), 1(1), Suppl. 1: 16, (2015). [tüm metin]
  • 13
    Foto E., Zilifdar F., Yildiz I., Diril N., "Investigation of Biological Activities of Some Newly Synthesized Benzoxazine Derivative", Turkish Journal of Biochemistry, 38(S1), (2013). [tüm metin]
  • 12
    Zilifdar F., Foto E., Aydogan Z., Aki-Sener E., Diril N., "Investigation of Cytotoxic and Genotoxic Potentials of 3 Heterocyclic Compounds", Turkish Journal of Biochemistry, 38(S1), (2013). [tüm metin]
  • 11
    AKI, E., YALCIN, I., YILDIZ, I., TEMIZ-ARPACI, O., BOLELLI, K., ERTAN-BOLELLI, T., DNA-Topoisomerase Inhibitory Activity of Some Heterocyclic Compounds and Their Structure-Activity Relationships", Med. Chem. Res., 19(Suppl.), S6, (2010). [tüm metin]
  • 10
    YALCIN, I., AKI, E., YILDIZ, O., TEMIZ-ARPACI, O., “Antimicrobial Activity and Structure-Activity Relationships of Some Synthesized Benzazoles and Their Possible Metabolites”, Med. Chem. Res. 19 (Suppl. 1), S41, (2010). [tüm metin]
  • 9
    I. Yildiz, S. Alper, T. Ertan, O. Temiz-Arpaci, B. Tekiner-Gulbas, E. Aki-Sener, I. Yalcin, "Molecular modelling studies on some eukaruotic topoisomerase II enzyme inhibitor fused heterocyclic compounds", Drugs of the Future, 32(A), 15-16 (Jul 2007). [tüm metin]
  • 8
    Hermann Lage, Sybille Kubald, Kishore Kumar Jella, Ismail Yalcin, Esin Aki-Sener, "Antineoplastic activity of heterocyclic compounds in multidrug-resistant cancer cells", Drugs of the Future, 32(A), 27-28 (Jul 2007).
  • 7
    TEMİZ-ARPACI, Ö., TEKINER-GULBAS, B., YILDIZ, İ., AKI-ŞENER, E., YALCIN, İ., "3D-QSAR Analysis on Benzazole Derivatives as Eukaryotic Topoisomerase II Inhibitors by using Comparative Molecular Field Analysis Method", QSAR and Molecular Modelling in Rational Design of Bioactive Molecules, Istanbul-Turkey, September 5-10, 2004, AKI-ŞENER, E., YALÇIN, İ. (Eds.), Başkent Publishing, Ankara, pp.396-398, (2006). [tüm metin]
  • 6
    Ozlem Temiz-Arpaci, Betul Tekiner-Gulbas, Ilkay Yildiz, Esin Aki-Sener, Ismail Yalcin, Nurten Altanlar, "Synthesis and Antifungal Activity of Some New 5-Ethylsulphonyl-2-substitutedbenzoxazoles", Scientia Pharmaceutica Supplement 1, 73(2): S235, (2005).
  • 5
    Ilkay Yildiz, Ozlem Temiz-Arpaci,Betul Tekiner-Gulbas, Tugba Ertan, Esin Aki-Sener, Ismail Yalcin, "COMFA 3D-QSAR Studies on Benzazole Derivatives as Eukaryotic Topoisomerase II Inhibitors", Scientia Pharmaceutica Supplement 1, 73(2): S234, (2005).
  • 4
    Esin Aki-Sener, Ismail Yalcin, "15th European Symposium on Quantitative Structure-Activity Relationships and Molecular Modelling (Euro-QSAR 2004)", QSAR & Combinatorial Science, 24(4), 441-441, (2005).DOI: 10.1002/qsar.200590024 [tüm metin]
  • 3
    VARGA, A., AKI-SENER, E., YALCIN, I., B., CHEREPNEV, G., MOLNAR, J., “Induction of Apoptosis and Necrosis by Resistance Modifiers Benzazoles and Benzoxazines on Tumour Cell Line Mouse Lymphoma L5718 MDR+Cells”, Anticancer Research, 24(5D), 3663-3663, (2004). [tüm metin]
  • 2
    Ismail Yalcin, Esin Aki-Sener, Ilkay Yildiz, "3D-QSAR LEAD OPTIMIZATION ANALYSIS OF SOME NOVEL EUKARYOTIC TOPOISOMERASE II INHIBITORS", Anticancer Research, 24(5D Suppl), 3673, (Sep-Oct 2004). [tüm metin]
  • 1
    AKBAY-YARPUZLU, A., YILDIZ, İ., TEMIZ-ARPACI, Ö., KARAGENÇ, N., AKI-ŞENER, E., YALÇIN, İ., “Adenosine Deaminase Inhibitor Activity of Some Benzoxazole, Benzimidazole, and Oxazolo(4,5-b)pyridine Derivatives”, XIII. Biotecnological Congress Proceedings Book, Çanakkale, 21-26, (2003).